Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Glioblastoma Multiforme · Glioblastoma · Glioma · Brain Tumor · Neoplasms · Neoplasms, Nerve Tissue

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Virginia, Charlottesville, Virginia, United States
Contact: Study coordinator (Jason Sheehan, M.D., Ph.D.) · JPS2F@uvahealth.org
Contact: Study coordinator (Arthur Lung, Ph.D.) · arthur.lung@navifus.com · 02-25860560

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Glioblastoma · Anaplastic Astrocytoma · Anaplastic Oligoastrocytoma

Abroad (travel likely)RecruitingPHASE2

New York, United States

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Glioma · Medulloblastoma · Ependymoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

WBSI Guided Personalized Delivery of TTFields

GBM · Glioma Glioblastoma Multiforme · Tumor, Brain

Abroad (travel likely)Recruiting

Philadelphia, United States · Philadelphia, United States

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

Ependymoma · Medulloblastoma · Glioblastoma

Abroad (travel likely)RecruitingPHASE1

Augusta, United States